Catalyst Wire Dossier Catalyst Wire Dossier

Brepocitinib

brepocitinib · Priovant Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Brepocitinib, covering 2025-05-18 to 2026-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]

See pricing